Prostate cancer molecular subtypes in systematic versus <scp>MRI</scp> ‐targeted biopsy cores at active surveillance: association of <scp>PTEN</scp> and <scp>ERG</scp> status with extreme grade reclassification
Claire M. de la Calle(Johns Hopkins University), Tamara L. Lotan(Johns Hopkins University)
Cited by 0
Related Papers
PTEN Protein Loss by Immunostaining: Analytic Validation and Prognostic Indicator for a High Risk Surgical Cohort of Prostate Cancer Patients
|Clinical Cancer Research|2011|350
Association of tumor-infiltrating T-cell density with molecular subtype, racial ancestry and clinical outcomes in prostate cancer
|Modern Pathology|2018|100
Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH
|Modern Pathology|2016|90
mTORC1 loss impairs epidermal adhesion via TGF-β/Rho kinase activation
|Journal of Clinical Investigation|2017|40